| David Lee Blemker, MD | |
|
5330 E Stop 11 Rd, Indianapolis, IN 46237-6345 | |
| (317) 893-1900 | |
| (317) 893-1901 |
| Full Name | David Lee Blemker |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 39 Years |
| Location | 5330 E Stop 11 Rd, Indianapolis, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093829236 | NPI | - | NPPES |
| P00671934 | Other | RR MEDICARE | |
| 100341620B | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 01035286A (Indiana) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 01035286A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Franciscan Health Mooresville | Mooresville, IN | Hospital |
| Franciscan Health Indianapolis | Indianapolis, IN | Hospital |
| Indiana University Health | Indianapolis, IN | Hospital |
| Columbus Regional Hospital | Columbus, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Franciscan Physician Network | 3072790682 | 989 |
News Archive
An international research team led by medical scientists at the University of Alberta has shown that new medications based on resveratrol - a compound found in red wine and nuts - may be used to treat a common heart-rhythm problem known as atrial fibrillation.
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better, announced today that it has secured $20 million in Series B funding from investors including Kleiner Perkins Caufield & Byers (KPCB), DFJ and previous investor General Catalyst.
BioTime, Inc. today reported recently-released results from an independent study evaluating the use of Hextend® in hemodynamically unstable trauma patients. Hextend (6% Hetastarch in Lactated Electrolyte Injection) is BioTime's commercially-available blood plasma volume expander used to treat hypovolemia (low blood volume). The study, conducted at the University of Miami Ryder Trauma Center, reported that initial resuscitation with Hextend was associated with no obvious coagulopathy and reduced mortality compared to fluid resuscitation without Hextend.
With Hurricane Irma fast approaching Florida, preparing for a disaster can feel overwhelming. But for people with diabetes, preparing for the worst is a matter of survival. Janis Roszler, LMFT, RD, LD/N, CDE, FAND, American Association of Diabetes Educator member, shares her checklist for staying safe.
› Verified 3 days ago
| Entity Name | Franciscan Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225327984 PECOS PAC ID: 3072790682 Enrollment ID: O20110608000486 |
News Archive
An international research team led by medical scientists at the University of Alberta has shown that new medications based on resveratrol - a compound found in red wine and nuts - may be used to treat a common heart-rhythm problem known as atrial fibrillation.
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better, announced today that it has secured $20 million in Series B funding from investors including Kleiner Perkins Caufield & Byers (KPCB), DFJ and previous investor General Catalyst.
BioTime, Inc. today reported recently-released results from an independent study evaluating the use of Hextend® in hemodynamically unstable trauma patients. Hextend (6% Hetastarch in Lactated Electrolyte Injection) is BioTime's commercially-available blood plasma volume expander used to treat hypovolemia (low blood volume). The study, conducted at the University of Miami Ryder Trauma Center, reported that initial resuscitation with Hextend was associated with no obvious coagulopathy and reduced mortality compared to fluid resuscitation without Hextend.
With Hurricane Irma fast approaching Florida, preparing for a disaster can feel overwhelming. But for people with diabetes, preparing for the worst is a matter of survival. Janis Roszler, LMFT, RD, LD/N, CDE, FAND, American Association of Diabetes Educator member, shares her checklist for staying safe.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Lee Blemker, MD Po Box 781076, Detroit, MI 48278-1076 Ph: (317) 528-4800 | David Lee Blemker, MD 5330 E Stop 11 Rd, Indianapolis, IN 46237-6345 Ph: (317) 893-1900 |
News Archive
An international research team led by medical scientists at the University of Alberta has shown that new medications based on resveratrol - a compound found in red wine and nuts - may be used to treat a common heart-rhythm problem known as atrial fibrillation.
Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.
Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better, announced today that it has secured $20 million in Series B funding from investors including Kleiner Perkins Caufield & Byers (KPCB), DFJ and previous investor General Catalyst.
BioTime, Inc. today reported recently-released results from an independent study evaluating the use of Hextend® in hemodynamically unstable trauma patients. Hextend (6% Hetastarch in Lactated Electrolyte Injection) is BioTime's commercially-available blood plasma volume expander used to treat hypovolemia (low blood volume). The study, conducted at the University of Miami Ryder Trauma Center, reported that initial resuscitation with Hextend was associated with no obvious coagulopathy and reduced mortality compared to fluid resuscitation without Hextend.
With Hurricane Irma fast approaching Florida, preparing for a disaster can feel overwhelming. But for people with diabetes, preparing for the worst is a matter of survival. Janis Roszler, LMFT, RD, LD/N, CDE, FAND, American Association of Diabetes Educator member, shares her checklist for staying safe.
› Verified 3 days ago
Irene A Carrothers, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1701 Senate Blvd, Indianapolis, IN 46202 Phone: 317-963-8776 Fax: 317-963-5285 | |
Liam P Howley, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1001 West 10th St Opw-m200, Indiana University Department Of Medicine, Indianapolis, IN 46202 Phone: 317-630-6560 | |
Cristina Nancy Perez Chumbiauca, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd, Indianapolis, IN 46202 Phone: 317-944-5000 | |
Dr. Andrew Jonathen Ortega, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 702 Rotary Cir, Indianapolis, IN 46202 Phone: 317-278-4427 | |
Lawrence John Born, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8424 Naab Rd, #3-j, Indianapolis, IN 46260 Phone: 317-872-7396 Fax: 317-879-8328 | |
Brian T Robinson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1001 W 10th St, Indianapolis, IN 46202 Phone: 317-630-7979 Fax: 317-630-2668 | |
Steven T Hugenberg, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd, Indianapolis, IN 46202 Phone: 317-944-8660 |